The Official Website of the Long-Term Investor
BATS data provided in real-time. NYSE, NASDAQ and NYSEMKT data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates, Analyst Ratings and Key Statistics provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions
RSS Headlines
Fool UK
Recs
It is the only company that is already selling a premium product line in the market. It has made smart strategic partnerships with larger, complementary organizations. It continues to devote tremendous resources to R&D as it seeks to expand it's potential markets far beyond biofuels. They have spent money to protect that R&D through patents. These patents have been wide ranging, extending it's potential into medical, nutritional, agricultural markets. As many know, building up a portfolio of IP grants one a substantial moat against competition. I actually view this as a biotech play rather than a biofuel play for both the near and long term. Speculative? Of course. Foolish? Only in the best sense of this site.